<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03992924</url>
  </required_header>
  <id_info>
    <org_study_id>FFR-1</org_study_id>
    <nct_id>NCT03992924</nct_id>
  </id_info>
  <brief_title>Physiology &amp; Optical Coherence in STEMI</brief_title>
  <official_title>A Prospective Evaluation of Clinical Impact of Physiology &amp; Optical Coherence Tomography Guided PCI in STEMI Patients Without Undergoing Primary PCI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shenyang Northern Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shenyang Northern Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to prospectively evaluate the outcomes of different treatment
      pathways using a Physiology &amp; Imaging guided PCI in patients with STMEI.

      A multi-centre study that will prospectively enrol consecutive STEMI patients who don't
      receive primary PCI within 48 hours after symptom onset because of different reasons.

      STEMI patients with culprit lesion stenosis between 0%-90% will be included in this study and
      randomized to angiography-guided, FFR-guided or OCT guided PCI groups.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2019</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>One-year target lesion failure (TLF)</measure>
    <time_frame>12 month</time_frame>
    <description>a composite of cardiac death, target vessel myocardial infarction (TV-MI), or clinically indicated target lesion revascularization (TLR).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of Major Adverse Cardiovascular Events (MACE)</measure>
    <time_frame>12 month</time_frame>
    <description>Death from cardiac causes, ARC defined Stent Thrombosis, Non-fatal MI, Clinically driven target vessel revascularization (TVR) or re-hospitalization due to unstable or progressive angina</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>angiography-guided PCI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>FFR-guided PCI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>OCT-guided PCI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>function or imaging guided PCI</intervention_name>
    <description>FFR may be good tools to differentiate patients with STEMI who may not need stent implantation from those who need Optical coherence tomography (OCT) can visualize the microstructure of culprit and the OCT characteristics were validated by histology</description>
    <arm_group_label>FFR-guided PCI</arm_group_label>
    <arm_group_label>OCT-guided PCI</arm_group_label>
    <arm_group_label>angiography-guided PCI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Age ≥18 years STEMI for 7-30 days Have not undergone PCI because: Stabilization in a
        non-PCI hospital followed by transfer to a tertiary hospital for further
        evaluation;Previous emergent angio without ballooning or stenting;Previous emergent
        Thrombus Aspiration without ballooning or stenting;Pharmacoinvasive therapy Stenosis
        between 0%-90% TIMI flow grad 3

        Exclusion Criteria:

        - Left main disease or bypass disease Intolerance to a study drug, metal alloys, or
        contrast media Life expectancy less than one year Previous PCI or CABG history Cardiogenic
        shock or LVEF&lt;35% Severe renal or hepatic dysfunction, hemodynamic instability &gt;90%
        stenosis in culprit lesion TIMI flow ≤ grade 2 Planned surgery within 6 months after index
        procedure Clinical indications of inability to tolerate DAPT for 12 months Inability to
        provide written informed consent Participation in another trial before reaching the primary
        endpoint
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>General Hospital of Northern Theater Command</name>
      <address>
        <city>Shenyang</city>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Kai Xu</last_name>
      <phone>+86-24-28897309</phone>
      <email>xukai2001@sina.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 19, 2019</study_first_submitted>
  <study_first_submitted_qc>June 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 20, 2019</study_first_posted>
  <last_update_submitted>June 19, 2019</last_update_submitted>
  <last_update_submitted_qc>June 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shenyang Northern Hospital</investigator_affiliation>
    <investigator_full_name>Han Yaling</investigator_full_name>
    <investigator_title>director of department of cardiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

